Investment Committee Summary
| Rating | SELL |
| Internal 5-tier | STRONG SELL |
| Classification · conviction | speculative growth · medium |
| Evidence | 7/8 load-bearing inputs sourced — missing: Capex |
| Triangulated fair value | $289 (-69% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $309 (-67% vs spot · 12m PWEV) |
| Next catalyst | 2026-09-30 — Quarterly earnings |
| Primary thesis-break | FY revenue ($B) < 61.56 (next reported fiscal year) |
Decision detail — rating tables & Research OS strip
Rating: SELL
Internal 5-tier: STRONG SELL · speculative growth · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $933 |
| Triangulated Fair Value | $289 (-69% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $309 (-67% vs spot · 12m PWEV) |
| Forward P/E | 33.3x |
| Market Cap | $1.07T |
| 52-Week Range | $118–$1,213 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across three weighted anchors — a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-28. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 50.8/100 | -66% 1yr expected | Hold | Put Debit Spread | 31d — Quarterly earnings |
Research rating: SELL · Tactical / decision-rule stance: Hold — the stance is the machine decision-rules layer (hysteresis, kill-switches, freshness); the rating is the valuation verdict. They may diverge and are reconciled in the Decision Rules section below.
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: SELL
Defensive: rating SELL; triangulated fair value $289 (-69% vs spot) — the risk/reward is skewed to the downside on Revenue Growth. The debate is Revenue Growth — a fundamental call. SBC runs $0.8bn TTM (~1% of revenue; charged once, as dilution).
Investment Thesis
The bull case — 'HBM Supercycle' (8% weight) — targets $700, -25% vs spot. It needs Revenue Growth to surprise to the upside.
The dashboard below is the whole argument on one page: spot ($933) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Cycle Bust (Structural)' (25%) — targets $60.00, -94% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
Revenue Growth explains 45% of Monte Carlo outcome variance — the single variable that decides which side is right.
What the Market Is Pricing In
At the current price, the market pays 12.7× consensus forward EPS, vs the house DCF terminal 12.0×, and a peer median 13.0×. The house DCF sits 85% below spot, so the market is pricing in more than the house case — roughly 175.4pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 129.7 | 65.0 | High |
| EPS | 73.4 | 28.0 | Medium |
| Target price | 1,515.1 | 490.2 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Cycle Bust (Structural)' downside ($60.00) to a 'HBM Supercycle' bull case ($700); the probability-weighted blend (PWEV $309) is -67% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Cycle Bust (Structural) | 25% | $60.00 | -94% |
| Recession | 18% | $150 | -84% |
| Base | 35% | $400 | -57% |
| ME Bull | 14% | $550 | -41% |
| HBM Supercycle | 8% | $700 | -25% |
| Probability-Weighted (PWEV, after SBC dilution) | — | $309 | -67% |
SBC charge: scenario targets are gross per-share prices; the PWEV is reduced by one year of stock-based-compensation dilution (2.0% of shares, on SBC ≈ 3% of revenue), trimming the gross PWEV of $315 to $309 (-2.0%). SBC is charged once, as dilution — never also deducted from FCF.
Scenario rationale — the driver path behind every target:
- Cycle Bust (Structural) (25%, $60.00). Commodity DRAM/NAND ASPs roll over as capacity added at the peak meets softening demand; Chinese (CXMT/YMTC) supply structurally oversupplies the low end. Op margin collapses toward break-even or NEGATIVE as in FY23; even an HBM ramp cannot offset a commodity-bit price crash. The market capitalizes trough EPS on a low ~6-8x multiple. Target sits WELL BELOW the 52-week low — a genuine structural impairment given the cycle-peak entry price, not a pullback. Drivers — dram asp: -40% or worse; bit growth: demand soft; hbm mix: ramps but can't offset; op margin: ~0% to negative; multiple: ~6-8x trough.
- Recession (18%, $150). Broad demand weakness (PC/mobile/enterprise) pulls commodity ASPs down sharply while HBM holds on contracted pricing. Op margin compresses to high-single/low-double digits as commodity bits drag the blend. The multiple stays capped ~8-10x — the market refuses to pay up off falling earnings. Drivers — dram asp: -20-30%; bit growth: below trend; hbm mix: stable; op margin: ~10-15%; multiple: ~8-10x.
- Base (35%, $400). Cycle normalizes off the peak: commodity ASPs ease modestly while HBM and high-cap DC DRAM grow share, cushioning the blend. Op margin settles to a mid-cycle ~25-30% — above trough, well below peak. The multiple holds ~10-12x mid-cycle as the market treats current earnings as elevated but not collapsing. Drivers — dram asp: -10-15% off peak; bit growth: ~15%; hbm mix: rising; op margin: ~25-30%; multiple: ~10-12x.
- ME Bull (14%, $550). Memory stays tight: disciplined industry supply meets resilient AI + data-center demand, so commodity ASPs hold and HBM premium persists. Op margin sustains a peak-ish ~38-42% for longer than a normal cycle. The multiple expands to ~12-14x as investors give partial credit for cycle elongation. Drivers — dram asp: flat to +5%; bit growth: ~18-20%; hbm mix: high; op margin: ~38-42%; multiple: ~12-14x.
- HBM Supercycle (8%, $700). AI accelerator demand makes HBM the dominant margin driver and reshapes Micron's mix toward contract-priced, less-cyclical memory; HBM and high-cap DC DRAM scale enough to durably lift through-cycle margins. The market grants a structurally higher ~14-16x multiple on the view that mix shift has muted the historic cyclicality. NOTE: this is the least-likely leg given the oligopoly's capacity race and remains exposed if AI capex digests. Drivers — dram asp: firm; bit growth: >20%; hbm mix: very high / sold out; op margin: >42%; multiple: ~14-16x.
Valuation Triangulation
Three weighted anchors — a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $207 | -78% | 30% (declared 15%) |
| Peer P/E re-rate | multiple | $364 | -61% | 20% (declared 10%) |
| Peer EV/Revenue re-rate | multiple | $105 | -89% | 0% — cross-check only |
| Scenario PWEV | multiple | $309 | -67% | 50% (declared 25%) |
| DCF (5-year + terminal) | cash flow + terminal × | $137 | -85% | 0% — excluded |
| Triangulated (weighted) | — | $289 | -69% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name DCF, sum-of-parts are not computed, so 50% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
DCF excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $207 and 2% of paths finish above spot. The variance decomposition shows the revenue growth is the dominant swing factor (45% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 12.0%, 12.0x terminal FCF multiple → $137. Excluded from the weighted blend as an outlier — retained as an independent cross-check on the multiple-driven anchors.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 13.0x) implies $364. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 20% so market sentiment does not set the fair value.
Across all anchors the spread is 125% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 8.4x | 10.2x | 12.0x | 13.8x | 15.6x |
|---|---|---|---|---|---|
| 10.0% | $121 | $134 | $147 | $160 | $173 |
| 11.0% | $117 | $129 | $142 | $154 | $167 |
| 12.0% | $113 | $125 | $137 | $149 | $161 |
| 13.0% | $110 | $121 | $133 | $144 | $156 |
| 14.0% | $106 | $117 | $128 | $139 | $150 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $117 | $127 | $138 | $148 | $159 |
| -1.5pp | $115 | $126 | $138 | $149 | $160 |
| +0.0pp | $114 | $125 | $137 | $149 | $161 |
| +1.5pp | $111 | $124 | $136 | $149 | $161 |
| +3.0pp | $109 | $122 | $136 | $149 | $162 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Capex intensity ±15% | $93.00 | $181 | $88.00 |
| Op margin ±3pp | $114 | $161 | $47.00 |
| Terminal × ±15% | $125 | $149 | $24.00 |
| WACC ±1pp | $133 | $142 | $9.00 |
| Revenue CAGR ±3pp | $138 | $136 | $2.00 |
Company lever — SoP/share vs Compute & Networking (incl. HBM + DC DRAM) multiple (AI re-rating) (base 12.0x)
| Multiple | 8.4x | 10.2x | 12.0x | 13.8x | 15.6x |
|---|---|---|---|---|---|
| SoP/share | $136 | $157 | $177 | $197 | $218 |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| WDC | 12.0× | 15% | 13% | broad | 25% |
| STX | 14.0× | 18% | 18% | segment | 50% |
| SNDK | 10.0× | 12% | 10% | broad | 25% |
| INTC | 22.0× | 4% | 8% | segment | 50% |
Quality-weighted forward P/E: 15.7× (simple median 13.0×). Direct peers count 100%, segment 50%, broad 25%.
Valuation-anchor screen: DCF (exit) (excluded (>3× or <0.3× spot)); DCF (Gordon) (excluded (>3× or <0.3× spot)); Monte Carlo (excluded (>3× or <0.3× spot)). Anchor median 206.9. Extreme/excluded anchors carry no headline weight.
Historical-range cross-check: 52-week range $118–$1,213, centre $379 (-59% vs spot); spot sits at the 74th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $289 (-69% vs spot · triangulated FV) |
| Downside to bear case (Cycle Bust (Structural)) | $60.00 (-94% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Margin of safety (FV vs spot) | -222% |
| P(price > spot) — Monte Carlo | 2% |
That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (HBM Supercycle): $700.
Company Overview & Business Model
Micron Technology — TECHNOLOGY · SEMICONDUCTORS. Micron Technology, Inc. is an American producer of computer memory and computer data storage including dynamic random-access memory, flash memory, and USB flash drives. It is headquartered in Boise, Idaho.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Compute & Networking (incl. HBM + DC DRAM) | 55% | +60% | 40% | HBM share into AI accelerators (the AI engine) |
| Mobile | 16% | +5% | 20% | Smartphone unit demand |
| Embedded (auto / industrial) | 14% | +10% | 22% | Automotive memory content per vehicle |
| Storage (NAND / SSD) | 15% | +15% | 12% | NAND bit demand (data-center SSD) |
Edge. Narrow moat — Commodity DRAM/NAND has no durable moat — ASPs are set by industry supply, not Micron — so the terminal multiple must stay low (~8-11x mid-cycle), NOT the ~16x market. The only structurally-differentiated asset is HBM (3-player oligopoly, qualification lock-in). FALSIFIABLE: if HBM commoditises (CXMT/Samsung close the gap and HBM gross margin falls toward commodity-DRAM levels), even the ~10x is too generous and trough capitalisation applies.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Compute & Networking (incl. HBM + DC DRAM) | $32B | 55% | 60% | 40% | $12.8B | 12.0x | 35% | FACT/ESTIMATE |
| Mobile | $9B | 16% | 5% | 20% | $1.8B | 8.0x | 30% | FACT/ESTIMATE |
| Embedded (auto / industrial) | $8B | 14% | 10% | 22% | $1.8B | 11.0x | 30% | FACT/ESTIMATE |
| Storage (NAND / SSD) | $9B | 15% | 15% | 12% | $1.1B | 7.0x | 30% | FACT/ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
AI revenue, decomposed — the AI lines broken out (Azure-AI / Copilot / model-API / pass-through style), so the AI contribution is auditable:
| AI line | Run-rate | Growth | Gross margin | Capex % | Tag |
|---|---|---|---|---|---|
| HBM (high-bandwidth memory) | $14B | 70% | 55% | 40% | ESTIMATE |
| High-cap data-center DRAM (non-HBM) | $14B | 45% | 42% | 35% | ESTIMATE |
| Commodity DRAM + NAND (the rest) | $30B | 20% | 30% | 30% | ESTIMATE |
- HBM (high-bandwidth memory): STRUCTURAL-GROWTH piece. Sold into AI GPUs/accelerators; supply-constrained and multi-year sold-out; premium price/margin vs commodity DRAM. The one genuinely differentiated, contract-priced product line — least cyclical.
- High-cap data-center DRAM (non-HBM): AI-adjacent: high-density server DRAM modules (DDR5/high-cap) pulled by data-center build-out. More cyclical than HBM — still exposed to commodity DRAM ASP swings.
- Commodity DRAM + NAND (the rest): CYCLICAL base, NOT structural. Mobile/PC/consumer DRAM and NAND/SSD. ASP-driven; margin can swing from negative (trough) to >40% (peak). This is the bulk of revenue and the source of the boom/bust — do not capitalize peak margins here.
Named Exposures
Memory cycle (commodity ASP) (FACT/INFERENCE)
| Dimension | Assessment |
|---|---|
| Cyclicality | DRAM/NAND are commoditized; ASP is set by industry supply vs demand, not by Micron. Op margin has historically swung from NEGATIVE at trough to >40% at peak within ~2-3 years. |
| Current position | Spot $1048 reflects a CYCLE PEAK — forward |
| Boom/bust history | FY18 peak → FY19-20 bust (op margin collapsed); FY22 peak → FY23 trough (company posted operating LOSSES, gross margin went negative). The pattern recurs roughly every 2-4 years. |
| Why the multiple stays low | Markets refuse to capitalize peak earnings. Memory trades ~8-15x mid-cycle (often <5x ON PEAK EPS precisely because peak EPS is not durable). Capitalizing peak EPS at a high multiple is the classic value trap. |
| Capex intensity | ~30-35% of revenue — among the heaviest in tech. Cuts FCF and amplifies the cycle: capacity added at the peak floods the next trough. |
HBM / AI demand & China (ESTIMATE/INFERENCE)
| Dimension | Assessment |
|---|---|
| HBM supply agreements | HBM largely sold out / contracted multiple quarters forward at fixed prices — the most visible, least-cyclical revenue Micron has. Materiality is rising but still a minority of total bits. |
| AI-capex dependence | HBM demand is hostage to hyperscaler AI capex. A pause or digestion in AI accelerator build-out would remove the one structural growth leg and re-expose Micron to commodity dynamics. |
| Competitor dynamics | Oligopoly of three — Micron vs SK Hynix and Samsung (Korea). SK Hynix leads HBM; all three are racing capacity. HBM premium margins compress as Samsung/SK ramp supply — the structural-growth story can commoditize too. |
| China / export | Export controls and Chinese demand/retaliation are two-sided: China is a large memory buyer AND a subsidized entrant (CXMT/YMTC) adding commodity DRAM/NAND supply — a long-run structural-oversupply risk at the low end. |
| Concentration | AI/HBM revenue concentrated in a handful of accelerator customers; loss of a socket or qualification slip is a step-change risk. |
Industry Context — AI Compute Stack
This name sits in the AI Compute Stack cluster as a supplier — HBM / memory name. PARTIAL AI play: HBM sold into AI GPUs (premium, supply-tight) is AI-capex-linked; commodity DRAM/NAND is a SEPARATE memory cycle. So MU's downside blends an AI bust AND a commodity glut. Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: MSFT (buyer (hyperscaler)) · GOOGL (buyer (hyperscaler)) · AMZN (buyer (hyperscaler)) · META (buyer (hyperscaler)) · NVDA (supplier — AI accelerators) · LRCX (supplier — wafer-fab equipment) · MU (supplier — HBM / memory)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| AI Capex Bust | FY27 aggregate −30%+ (to ~$350B) | 22% | 25% |
| Digestion | FY27 flat / plateau (~$430-460B) | 20% | 18% |
| Sustained Build | FY27 +15-20% (to ~$500B) | 38% | 35% |
| Supercycle | FY27 +30%+ (to ~$600B+) | 20% | 22% |
Mapping note: name-level 'ME Bull' (14%) + 'HBM Supercycle' (8%) map to cluster Supercycle (22%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — AI Capex Bust (FY27 aggregate −30%+ (to ~$350B)) — this name implies 25% vs the cluster house view of 22% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Concentration — Demand: 4 hyperscalers ≈ 60-70% of AI capex. Supply: NVDA dominates accelerators; TSMC is the single leading-edge fab; 3 HBM makers. (FACT/ESTIMATE). Barriers — CUDA software lock-in, HBM/CoWoS packaging supply, leading-edge fab access, networking (NVLink). (FACT). Pricing Power — Sits with NVDA today (~75% gross margin); erodes if custom ASICs (Google TPU, AWS Trainium, Meta MTIA) and AMD take share, or inference shifts to cheaper compute. (INFERENCE). Substitution Risk — Custom silicon, model-efficiency gains (DeepSeek-style $/token collapse), inference-vs-training mix shift, and the circular vendor-financing of neoclouds/OpenAI. (INFERENCE).
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $5.0B — modestly levered |
| Net debt / EBITDA | 0.07x |
| Interest coverage (EBIT / interest) | 21.3x |
| Current ratio | 2.52x |
| Lease obligations | $3.7B |
| Cash & ST investments | $10.3B |
Balance-sheet data as of 2025-08-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $1.7B |
| Buybacks / dividends | $0.0B / $0.5B |
| Total shareholder yield | 0.0% |
| Payout as % of FCF | 31.3% |
| Reinvestment (capex / OCF) | 90.5% |
| SBC as % of FCF | 58.3% |
| Allocation stance | balanced |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 2.9% |
| FCF conversion (FCF / net income) | 19.5% |
| FCF yield | 0.2% |
| Capex intensity (capex / revenue) | 27.3% |
| FCF − SBC (diagnostic) | $0.7B |
| Capex split (maint / growth) | 30% / 70% — Memory is capital-intensive; the majority of capex is growth (greenfield fabs, HBM/leading-node capacity). Heavy growth capex at a cycle peak is the mechanism that seeds the next bust. |
Accounting quality: SBC 3% of revenue; cash conversion (OCF/NI) 205% — cash-backed.
Competitive Moat
Moat sources:
- HBM: effective 3-player oligopoly (Micron/SK Hynix/Samsung) with multi-year qualification and sold-out capacity — the one narrow moat
- Absence of moat in commodity DRAM/NAND: price-taker, ASP set by industry supply/demand
- Process-technology cadence / capital scale as a cost position (not a pricing moat)
- Chinese entrants (CXMT/YMTC) structurally erode the low-end, capping any moat premium
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q3): management +0.67 vs analyst floor +0.00 → delta +0.67 (n=14 mgmt / 12 Q&A; 95th pctile across the S&P book, z +1.7).
Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q3 | +0.67 | +0.00 | +0.67 |
| 2026Q2 | +0.52 | +0.07 | +0.45 |
| 2026Q1 | +0.51 | +0.24 | +0.28 |
| 2025Q4 | +0.70 | +0.30 | +0.40 |
News (last 365d, 2689 articles): avg ticker sentiment +0.13 (bullish 17% / bearish 6%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $1,515 (+62% vs spot · street) |
| House target | $490 (-67.6% vs street) |
| Sell-side coverage | 45 analysts (SB 9 / B 31 / H 5 / S 0 / SS 0; net score 0.54) |
| Consensus FY EPS | $73.40; house below (-61.9%) |
| Consensus FY revenue | $129.7B; house below (-49.9%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-09-30 (~33d) — Quarterly earnings — est. EPS $31.17 (AV EARNINGS_CALENDAR)
- 2026-10-15 (~48d) — HBM4 qualification / hyperscaler design-win confirmation (authored)
- 2026-12-10 (~104d) — FY27 capex plan / greenfield fab (Idaho/NY) cadence (authored)
- 2027-02-15 (~171d) — Industry DRAM/NAND ASP inflection signpost (authored)
Forecast Track Record
- EPS surprise: beat 100% of the last 8 quarters; average surprise +15.4%.
- Prior-forecast backtest (13 snapshots, 2026-04-24→2026-08-25): directional hit-rate 69%; mean predicted -40.2% vs realised +12.1%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
6 catalysts in the next 90 days (of 16 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 17d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 19d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-09-30 (in 31d) | Quarterly earnings | earnings | ●●● | 0.95 |
| 2026-10-14 (in 45d) | September CPI | macro | ●● | 0.8 |
| 2026-10-15 (in 46d) | HBM4 qualification / hyperscaler design-win confirmation | authored | ● | 0.7 |
| 2026-10-28 (in 59d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 101d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-10 (in 102d) | FY27 capex plan / greenfield fab (Idaho/NY) cadence | authored | ● | 0.7 |
| 2026-12-18 (in 110d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 150d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-02-15 (in 169d) | Industry DRAM/NAND ASP inflection signpost | authored | ● | 0.7 |
| 2027-03-17 (in 199d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 201d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 241d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| US-China export controls, tariffs and China's CAC review restricting Micron sales into China | high (~55%) | medium - China direct/indirect exposure; a hard restriction is worth ~5-10% of FV | 12-24m |
| CHIPS Act grant / clawback conditions and foreign-subsidy scrutiny on new fabs | medium (~35%) | low - affects funding of growth capex, ~2-4% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| ME Bull | Demand stays firm, ASPs hold and HBM ramps ahead of plan, sustaining above-mid-cycle margins for longer. | The market still refuses to capitalise near-peak earnings, so the multiple caps upside even if earnings deliver. |
| HBM Supercycle | AI-accelerator HBM demand outruns supply for multiple years, structurally lifting the blended margin and partially de-commoditising the mix. | HBM competition (SK Hynix/Samsung/CXMT) closes the gap and the supercycle premium proves temporary. |
Scenario-macro rows withheld pending re-authoring: 3 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 1 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
-47.45 | YES |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
-47.45 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.54 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
205.2 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.59 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.61 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- FY revenue ($B) < 61.56 (next reported fiscal year). (rationale withheld pending re-authoring — frozen figure or verdict)
- Probability-weighted fair value (PWEV) at the next re-run < 932.86 (any scheduled re-run). (rationale withheld pending re-authoring — frozen figure or verdict)
- Share price (close) < 60.0 (5 consecutive sessions). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $933; 52-week range $118–$1,213; engine rating SELL; house target $490 (-47%). (source: Alpha Vantage 2026-08-28, 30 August 2026)
- INFERENCE: Triangulated FV $289 (-69% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that Revenue Growth keeps surprising favourably — an operating call the next two prints will test.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
50.8/100 (confidence band 37.0–64.5). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 52 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 88 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 2 | 15% | upside_pct |
| growth | 70 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 100 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 57 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 59 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | 50 | 10% | industry_context.house |
| risk profile | 2 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Score history: 50.8 → 50.8.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Cycle Bust (Structural) | 25% | $60.00 | -93.6% | -23.4pp |
| Recession | 18% | $150 | -83.9% | -15.1pp |
| Base | 35% | $400 | -57.1% | -20.0pp |
| ME Bull | 14% | $550 | -41.0% | -5.8pp |
| HBM Supercycle | 8% | $700 | -25.0% | -2.0pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | -66.2% |
| Expected return net of SBC dilution | -66.9% |
| Outcome dispersion (σ, from MC p10–p90) | 20.3% |
| Expected Sharpe (rf 4%) | -3.46 |
| Downside expectation (prob-weighted loss branches) | -66.2% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 22.3% (1σ) | 41.9% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 0.0% | 1.8% | the two expressions of our own view agree |
| Realised scenario frequency | 2 dated anchors | — | only 2 dated anchors — below the 12 this check needs before it means anything. Reported so the absence is visible rather than looking like agreement. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $315.0.
Factor Exposures
Cross-sectional percentiles over 893 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 25 | AI | 100 | |
| Cloud | 81 | |||
| Semis | 100 | |||
| Momentum | 100 | Consumer | 91 | |
| Low-Vol | 2 | Rates | 73 | |
| USD | 4 | |||
| Energy | 2 |
Options Intelligence
Preferred structure: Put Debit Spread. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- bearish with cheap options — buy defined-risk downside
- Direction bearish from the overlay conviction/rating (read-only input).
- IV/RV at the 5th percentile of the cross-section → low vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- IV term structure is in contango (longer-dated richer, slope +12.7pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +12.7pp): 28-DTE 52% · 84-DTE 61% · 385-DTE 65%
| Priced structure | Value |
|---|---|
| Legs | Long 930 P, Short 650 P |
| Expiry | 2027-02-19 |
| Max loss | $112 |
| Max profit | $168 |
| Net debit | $112 |
| Return on risk | 151.0% |
| Breakeven | $818 |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: Protective Put. IV rank shown via the cross-sectional IV/RV percentile (interim) (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
research rating is SELL-tier — the model carries no long position.
| Parameter | Value |
|---|---|
| Initial position | 0.00% NAV |
| Maximum position | 0.00% NAV |
| Risk budget | 0.00% NAV |
| Annualized outcome σ (MC) | 20.3% |
| Indicative holding period | 3–12 months |
| Liquidity | high, ~$28,690M ADV (adv usd 21 (split-adjusted 21d average, AM-046)) |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the SELL equity view. Chain as of 2026-08-28 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 52.2% (subdued regime) · expected move ±11.6% (2026-09-25) · put/call OI 1.08 · ATM Δ 0.53 / Θ -1.00 / ν 1.03 · next earnings 2026-09-30. Direction: SHORT/HEDGE (implied return -69.0% to triangulated fair value $289.3).
Bear Put Spread (Bearish) — Long 930 P / Short 650 P · 2027-02-19 · net debit $111.62 · max profit $168.38 · breakeven $818.38 · RoR 151.0% · max loss $111.62 · priced from the listed chain (EOD marks)
Defined-risk downside expression: the debit caps the loss, with the position gaining as the stock falls toward the lower strike — a way to act on a bearish view without shorting stock. Subdued implied volatility currently lowers the premium paid. Illustrative — no outcome is implied or guaranteed.
Protective Put (if held) (Hedge) — Long 930 P · 2027-02-19 · premium $145.95 · floor 0.0% · max loss $145.95 · priced from the listed chain (EOD marks)
Insurance for an existing holding — a known premium buys a floor while leaving the upside intact. A way to hold through a binary event or volatility with defined downside.
Protective Collar (if held) (Hedge) — Long 840 P / Short 1030 C · 2027-02-19 · net $31.62 · floor -10.0% · cap +10.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = SELL because:
- Probability-weighted scenario value implies -67% vs spot
- Monte Carlo median implies -78% vs spot
- DCF fair value implies -85% vs spot
- Bear case (Cycle Bust (Structural)) downside is -94% vs spot
- Net: the valuation anchor itself sits 69.0% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating warrants a Sell.
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $84B | $29B | $28B | $28B | $26B | $23B |
| FY+2 | $97B | $29B | $32B | $28B | $22B | $18B |
| FY+3 | $102B | $20B | $33B | $29B | $14B | $10B |
| FY+4 | $92B | $5B | $30B | $30B | $4B | $2B |
| FY+5 | $101B | $18B | $33B | $31B | $14B | $8B |
| Terminal | — | — | — | — | $14B × 12.0x | $92B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 33% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 12.0% · Σ PV(FCF) $61B + PV(terminal) $92B = EV $153B; + net cash $5.0B → equity $158B ÷ diluted shares $1.15B = $137/share (exit-multiple terminal).
- Gordon terminal at 2.5% → $129/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ -6% vs WACC 12.0% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| WDC | 1.5x | 12.0x | 15% | 13% |
| STX | 2.5x | 14.0x | 18% | 18% |
| SNDK | 2.0x | 10.0x | 12% | 10% |
| INTC | 2.0x | 22.0x | 4% | 8% |
| Median | 2.0x | 13.0x | — | — |
Implied prices at the peer medians: peer-median fwd P/E → $364; EV/Rev → $105.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| Scenario PWEV | $309 | 50% | $154 |
| Monte Carlo median | $207 | 30% | $62.08 |
| Peer P/E | $364 | 20% | $72.80 |
| Triangulated | — | 100% | $289 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 12.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 12× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 2.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Capex intensity ±15% (88.0); Op margin ±3pp (47.0); Terminal × ±15% (24.0); WACC ±1pp (9.0); Revenue CAGR ±3pp (2.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $58.12B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $65.0B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $73.4004 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 1.15B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $4.971B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 12.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 12× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
| SBC dilution | 2.0%/yr | house estimate | From SBC/revenue | Medium | PWEV, MC, DCF (charged once) |
| AI revenue | see AI decomposition | inference | Derived from company comments | Low/Medium | Scenario analysis |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-30 (prices 2026-08-28) |
| Narrative authorship | MCH engine — systematic generation, drafted 2026-07-06 |
| Human review | engine output reviewed at the estate level, not name-by-name |
| Evidence | 7/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 12.0%, terminal multiple 12×, FY+5 revenue $101B. Triangulation leans 50% on PWEV, 30% on the Monte Carlo median, 20% on peer-implied value.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-28 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-08-28 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-28 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-28 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-28 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-28 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-28 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-28 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-28 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-28 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-28 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-28 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.